(Neglected) Infectious Diseases, such as malaria, TBC, HIV/AIDS, are still among the leading causes of death worldwide, especially in lower-middle income countries. Suriname has marked large successes in decreasing mortality by malaria through very efficient treatment, diagnostic and research programs. The research in this pillar does not only focus on known infectious diseases such as malaria, TBC and HIV/AIDs, but also lesser known emerging neglected infectious diseases such as Chagas and Histoplasmosis.
Suriname Meningitis Study
This study was initiated after Suriname Meningitis Study the sudden increase in (viral) meningitis cases at the AZP.
Artemisinine resistence of P. falciparum malaria in Suriname
The emerging resistance to artemisinin derivatives that has been reported in South-East Asia led us to assess the efficacy of artemether-lumefantrine as the first line therapy for uncomplicated Plasmodium falciparum infections in Suriname.
Management of HIV in Suriname
Management of HIV in Suriname; Treatment cascade & opportunistic infections.
Histoplasmosis in HIV positive adults
Histoplasmosis due to Histoplasma capsulatum var. capsulatum in the Guiana Shield and the French West Indies: Evaluating prevalence with a rapid diagnostic test using an ELISA capture method for the detection of Histoplasma antigens in blood and urine.
Hepatitis C prevalence in Suriname
Result Hepatitis C prevalence in Surinames from the Viral Hepatitis study among the Emergency Department population are in!